The results suggest that the expression of CXCL8 or LSECtin in colon cancer is significantly positively related with the infiltration of CD8+ T lymphocytes, DC cells, macrophages, and neutrophils, which is a key factor affecting the therapeutic efficacy of ICIs [24]. The gene discussed is CD8A; the disease is colonic neoplasm.